As Synopsys navigates the demanding post-acquisition integration of Ansys, the company has announced significant changes to its board of directors. This strategic reshuffle coincides with a notable downgrade from one major bank, creating a mixed outlook for investors ahead of the upcoming quarterly earnings report.
Leadership Changes During Critical Phase
In a move to bolster its financial oversight, Synopsys has appointed Peter A. Shimer, a former Deloitte executive, to its board and audit committee. The appointment is seen as particularly strategic, given the company’s ongoing efforts to integrate Ansys, a $35 billion acquisition finalized in July 2025. CEO Sassine Ghazi highlighted that Shimer’s financial and strategic expertise would be invaluable during this period of transformation. Concurrently, current board members Luis Borgen and Dr. Ajei Gopal have indicated they will not stand for re-election at the 2026 annual shareholder meeting.
A Split Verdict from Market Experts
Analyst sentiment currently presents a divided picture. HSBC revised its rating on Synopsys shares from “Buy” to “Hold” this Friday, simultaneously slashing its price target from $545 to $455. This cautious stance contrasts sharply with the continued optimism from other firms. Rosenblatt Securities, for instance, reaffirmed its “Buy” recommendation, maintaining a $560 price target. This divergence underscores market uncertainty regarding near-term valuation, even as the stock has declined approximately 7% since the start of the year.
Should investors sell immediately? Or is it worth buying Synopsys?
Fundamentally, the company’s recent performance provides a solid base. Last quarter’s revenue saw a significant boost of nearly 38%, bolstered by the consolidation of Ansys’s financials. Furthermore, a strategic $2 billion investment from partner Nvidia in December 2025 signaled strong confidence in the convergence of hardware design and artificial intelligence that Synopsys enables.
Upcoming Earnings in the Spotlight
All eyes are now on February 25, 2026, when Synopsys is scheduled to release its results for the first fiscal quarter. Investors will scrutinize whether the company confirms its full-year revenue guidance of $9.56 to $9.66 billion. A key focus will be the early signs of operational synergies from the Ansys integration and how effectively they are materializing in the new fiscal year.
Ad
Synopsys Stock: Buy or Sell?! New Synopsys Analysis from October 13 delivers the answer:
The latest Synopsys figures speak for themselves: Urgent action needed for Synopsys investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 13.
Synopsys: Buy or sell? Read more here...
